mortality/aging
|
• cumulative mortality 7 days after infection with Coxsackie virus is 25% as compared to 67% for controls
|
immune system
| N |
• despite near absence of IL-4-secreting NK-like T cells in the thymus, homozygotes are able to mount a normal TH2 response producing IgE levels comparable to those detected in control littermates after immunization with anti-IgD
|
myocarditis
(
J:126220
)
|
• reduced incidence of myocarditis caused by Coxsackie virus infection
|
|
• substantial reduction in airway eosinophilia in response to OVA challenge
|
|
• decreased Interferon gamma positive CD4+ cells
|
|
• homozygotes show near absence of the NK-like thymocyte population that secretes large amounts of IL-4 immediately after T cell receptor ligation and is characterized as heat-stable antigen (HAS)-/low, Vbeta8int CD44high (the
NK1.1 marker is not expressed in the 129 and BALB/c genetic background of homozygous mutant mice)
|
|
• in vivo, homozygotes fail to promptly produce IL-4 after intravenous injection with anti-CD3
• in contrast, the induction of IFN-gamma mRNA after T cell receptor ligation remains unaffected
|
|
• cumulative mortality 7 days after infection with Coxsackie virus is 25% as compared to 67% for controls
|
hematopoietic system
|
• substantial reduction in airway eosinophilia in response to OVA challenge
|
|
• decreased Interferon gamma positive CD4+ cells
|
|
• homozygotes show near absence of the NK-like thymocyte population that secretes large amounts of IL-4 immediately after T cell receptor ligation and is characterized as heat-stable antigen (HAS)-/low, Vbeta8int CD44high (the
NK1.1 marker is not expressed in the 129 and BALB/c genetic background of homozygous mutant mice)
|
neoplasm
|
• metastasis to the lung is reduced as measured by iv injection of colon carcinoma cell line CT26
|
cardiovascular system
myocarditis
(
J:126220
)
|
• reduced incidence of myocarditis caused by Coxsackie virus infection
|
respiratory system
|
• hyper-reactivity does not develop in response to OVA challenge
|


Analysis Tools